top of page
News, Events and Updates
Search
Anavex Life Sciences Announces Closing of $50 Million Registered Direct Offering
Jun 23, 2021
Anavex Life Sciences Announces $50 Million Registered Direct Offering
Jun 21, 2021
Anavex Life Sciences Announces ANAVEX®2-73 Biomarker Correlated with Efficacy Endpoint in Trial
Jun 20, 2021
Anavex Life Sciences Reports the Mechanism of ANAVEX®2-73 (blarcamesine) and ANAVEX®3-71 (AF710B)
Jun 13, 2021
Anavex Life Sciences Announces Exceeding of Enrollment Target for the Precision Medicine ANAVEX®2-73
Jun 7, 2021
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application ANAVEX®2-73
Jun 3, 2021
Anavex Life Sciences Announces Appointment of Ms. Jiong Ma, PhD to Board of Directors
May 26, 2021
Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial Results And Business Outlook
May 13, 2021
Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit
May 6, 2021
Anavex Life Sciences to Announce Fiscal 2021 2nd Quarter Financial Results and Business Outlook
May 5, 2021
Anavex Life Sciences Appoints Former FDA Officer Senior Vice President for Nonclinical Development
May 4, 2021
12
13
14
15
16
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
